Month: February 2018

The U.S. Energy Department's inventory release showed that crude stockpiles recorded a second straight weekly build. […]

Masco Corporation’s MAS fourth-quarter 2017 adjusted earnings per share of 44 cents surpassed the Zacks Consensus Estimate of 43 cents by 2.3%. Adjusted earnings increased 33% year over year. Net sales of $1.87 billion beat analysts’ expectation of $1.83 billion by about 2.2%. […]

Fiserv Inc. FISV delivered fourth-quarter adjusted earnings of $1.41 per share, which surpassed the Zacks Consensus Estimate of $1.37. The figure increased 21.6% on a year-over-year basis […]

CVS Health Corporation ’s CVS fourth-quarter 2017 adjusted earnings per share (EPS) of $1.92 were up 12.3% year over year. The adjusted EPS also beat the Zacks Consensus Estimate by 3 cents. […]

Manulife Financial Corporation MFC reported fourth-quarter 2017 core earnings of $949 million (C$1,205 million), up 6% year over year. Prudential Financial, Inc. Price, Consensus and EPS Surprise Prudential Financial, Inc […]

CBRE Group Inc. CBG reported fourth-quarter 2017 adjusted earnings per share of 99 cents, beating the Zacks Consensus Estimate of 93 cents. The figure also marked a 6% increase from the prior-year quarter tally of 93 cents […]

Prudential Financial, Inc. ’s PRU fourth-quarter 2017 adjusted net income of $2.69 per share beat the Zacks Consensus Estimate of $2.60 by 3.46%. […]

Yum! Brands YUM posted decent fourth-quarter 2017 results, beating the Zacks Consensus Estimate on earnings but missing the same on revenues. Adjusted earnings of 96 cents per share surpassed the Zacks Consensus Estimate of 80 cents. Further, earnings increased 21.5% year over year […]

SandRidge Energy, Inc. SD has recently been offered a merger deal from rival Midstates Petroleum Company MPO in an all-stock deal. The move, if it were to be agreed upon at somew poibnt in the future, would create one of the largest oil players in the Mississippian Lime shale formation. […]

Chesapeake Energy Corporation CHK recently provided a glimpse of its fourth-quarter 2017 production update. The upstream firm also provided details on deals signed for divesting non-core assets. Details on Production The company projects fourth-quarter 2017 production at 593,000 barrels of oil equivalent (BoE) per day, up 15% from a year ago and 10% from the previous quarter […]

BorgWarner Inc. BWA reported adjusted earnings of $1.07 per share in fourth-quarter 2017, beating the Zacks Consensus Estimate of $1.02. […]

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. […]

Yelp Inc. YELP reported fourth-quarter non-GAAP earnings of 19 cents per share, which declined 29.6% year over year. The Zacks Consensus Estimate was pegged at a loss of 25 cents. […]

Keryx Biopharmaceuticals Inc. KERX reported a loss of 26 cents per share in the fourth quarter of 2017, wider than Zacks Consensus Estimate of a loss of 18 cents. The loss was however narrower than the year-ago loss of 32 cents […]

T-Mobile US TMUS reported mixed financial numbers for the fourth quarter of 2017. The bottom line beat the Zacks Consensus Estimate, while the top line lagged the same. T-Mobile US carries a Zacks Rank #3 (Hold). […]

Premium consumer technology company iRobot Corporation IRBT reported strong fourth-quarter 2017 results. Earnings/Revenues Adjusted earnings during the quarter came in at 54 cents per share, beating the Zacks Consensus Estimate of 26 cents. […]

Tyson Foods, Inc. TSN posted first-quarter fiscal 2018 results, wherein earnings and sales grew year over year and surpassed the Zacks Consensus Estimate for the second straight time. Also, management raised its fiscal 2018 earnings outlook, on the back of the recent tax reforms […]

On Feb 7, we issued an updated research report on Illumina, Inc. ILMN — a Zacks Rank #3 (Hold) stock. […]

Novartis NVS announced that the FDA has approved a line extension for its IL-17A inhibitor drug, Cosentyx, in moderate-to-severe scalp psoriasis. The FDA approval comes on the back of positive efficacy and safety outcomes from a dedicated phase III study – SCALP – in patients with scalp psoriasis. We note that the drug was approved for a similar indication in Europe in June 2017. […]